<!DOCTYPE DOCUMENT SYSTEM "icon.dtd" []>

<DOCUMENT author="perl program" datec=020199 title="leaflet" book="ABPI" edition="1996-97" section="company">
<DIV type=0>

<HEAD>
Zoladex LA
</HEAD>


<BLOCK>
Please read this leafletcarefully. This leaflet only gives a summary of the information available on your medicine. If you have any questions or are not sure about anything, ask your doctor or pharmacist.
</BLOCK>

<DIV type=1>

<HEAD weight="bold" >
What you should know about your medicine
</HEAD>


<BLOCK>
The name of your medicine is Zoladex LA. The active ingredient is goserelin. Each Zoladex LA injection contains 10.8 mg of goserelin. It also contains lactide glycolide copolymer which is an inactive substance.
</BLOCK>


<BLOCK>
Zoladex is produced in packs of one injection.
</BLOCK>


<BLOCK>
Goserelin is one of a group of medicines called LHRH analogues. It reduces the production of testosterone in the body.
</BLOCK>


<BLOCK>
The product licence holder and manufacturer of Zoladex LA is Zeneca Limited, Macclesfield, Cheshire.
</BLOCK>


<BLOCK>
Zoladex LA is used to treat prostate cancer.
</BLOCK>


</DIV>
<DIV type=1>

<HEAD weight="bold" >
Before receiving your medicine
</HEAD>


<BLOCK>
Zoladex LA should not be given if you have previously had an allergic reaction to Zoladex or to this type of medicine.
</BLOCK>


<BLOCK>
Zoladex LA is a long-acting (12-weekly) form of Zoladex, and is not to be used by women.
</BLOCK>


<BLOCK>
Zoladex LA should not be given to children.
</BLOCK>


<BLOCK>
Have you had any problems passing urine or have you had any problems with your back? If so, tell your doctor.
</BLOCK>


<BLOCK>
If you go into hospital, tell the medical staff that you are receiving Zoladex LA.
</BLOCK>


</DIV>
<DIV type=1>

<HEAD weight="bold" >
Receiving your medicine
</HEAD>


<BLOCK>
Zoladex LA is given as an injection under the skin every 12 weeks by your doctor or a nurse. It is important that you keep on receiving your treatment, evenifyouarefeelingwell,unlessyourdoctordecides that it is time for the treatment to stop.
</BLOCK>


<BLOCK>

<EMPH weight="bold">
Ahter receiving your medicine
</EMPH>
 As with all medicines, undesirable events can some times be experienced with Zoladex LA. Since Zoladex
</BLOCK>


<BLOCK>
LA is a hormone medicine, it can cause rare allergic reactions, hot flushes and a decrease in libido and sometimes breast swelling and tenderness. In some men there can be bone pain or possibly some problems with passing urine at the beginning of treatment. If this happens, tell your doctor about it. Other possible undesirable events are skin rashes, pain in the joints, or changes in blood pressure.
</BLOCK>


<BLOCK>
Do not be alarmed by this list of possible events. You may not have any of them.
</BLOCK>


<BLOCK>
If you get any other undesirable events or if you think your medicine is causing any problems, tell your doctor or pharmacist.
</BLOCK>


</DIV>
<DIV type=1>

<HEAD weight="bold" >
Storing your medicine
</HEAD>


<BLOCK>
You may be given a prescription and asked to get your medicine from the pharmacy and keep it until you see the doctor again. Keep it in its original package and don't break the seal. Store it below 25oC and keep it in a safe place where children cannot see it or reach it.
</BLOCK>


<BLOCK>
Your medicine should not be used aher the expiry date on the carton.
</BLOCK>


<BLOCK>
If your medicine is not used, take it back to your pharmacist.
</BLOCK>


<BLOCK>
Date of preparation of leaflet: May 1996.
</BLOCK>


</DIV>
<DIV type=1>

<HEAD weight="bold" >
Further information
</HEAD>


<BLOCK>
This leaflet does not contain the complete information on Zoladex LA. If you have any questions, or are not sure about anything, ask your doctor or pharmacist.
</BLOCK>


<BLOCK>
The information applies only to Zoladex LA.
</BLOCK>


<BLOCK>
Zoladex is a trademark, the property of Zeneca Li m ited .
</BLOCK>


<BLOCK>
Zeneca Pharma, King's Court, Water Lane, Wilmslow, Cheshire SK9 5AZ.
</BLOCK>


<BLOCK>
Approved by the MCA on 12 June 1996 as UKPI 96/
</BLOCK>


<BLOCK>
UKPI 96/254.
</BLOCK>

</DIV>

</DIV>

</DOCUMENT>
